Gene therapy for neurodegenerative disorders
US12350311B2 · kind B2 · utility
0Cited by
53References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 26, 2024 |
| Grant date | Jul 8, 2025 |
| Priority date | — |
| Expiry date | Mar 26, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14171
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for treating disorders affecting motor function, such as motor function affected by disease or injury to the brain and/or spinal cord, are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.